LCM
ITCI
Legato Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-29,364
| Closed | -$2.45M | – | 637 |
|
|
2024
Q4 | $2.45M | Buy |
29,364
+9,541
| +48% | +$797K | 0.32% | 68 |
|
|
2024
Q3 | $1.45M | Sell |
19,823
-4,759
| -19% | -$348K | 0.18% | 187 |
|
|
2024
Q2 | $1.68M | Buy |
24,582
+9,923
| +68% | +$680K | 0.23% | 155 |
|
|
2024
Q1 | $1.01M | Buy |
14,659
+3,197
| +28% | +$221K | 0.12% | 269 |
|
|
2023
Q4 | $821K | Buy |
11,462
+6,491
| +131% | +$465K | 0.11% | 309 |
|
|
2023
Q3 | $259K | Sell |
4,971
-14,882
| -75% | -$775K | 0.04% | 494 |
|
|
2023
Q2 | $1.26M | Buy |
+19,853
| New | +$1.26M | 0.17% | 198 |
|
|
2023
Q1 | – | Sell |
-14,487
| Closed | -$767K | – | 536 |
|
|
2022
Q4 | $767K | Buy |
+14,487
| New | +$767K | 0.15% | 243 |
|
|
2021
Q3 | – | Sell |
-10,270
| Closed | -$419K | – | 331 |
|
|
2021
Q2 | $419K | Buy |
+10,270
| New | +$419K | 0.06% | 266 |
|